Discussions Around the DeLLphi-305 Trial
Sevabertinib Moves Into First-Line HER2-Mutant NSCLC With FDA Accelerated Approval
FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer
MOB-RT Supports Moderate Hypofractionated Pelvic Radiotherapy in High-Risk Prostate Cancer
Benjamin L. Ebert: A Major Step Forward for Personalized Cancer Vaccines
Vanessa Kerry։ Honored to Have Been Appointed as the Director-General's Special Envoy for Health Resilience
Hodgkin Lymphoma in 2026: What the New EHA Guidelines Recommend
Gilberto Lopes: DeLLphi-305 Signals a Potential Shift in First-Line SCLC
VIRO 2026 – Global Voices in Renal Oncology
O Series
Upcoming
Immunõ 2026: Global Virtual Congress on Immuno Oncology
O Series
Upcoming
The State of Oncology in 2026 With ZS
Upcoming
Mammo 2026: Global Breast Cancer Virtual Congress
O Series
Upcoming
L’Oncodaily Session during London Cancer Week 2026
Upcoming
LungÕ 2026 – Virtual Global Congress on Lung Oncology
O Series
Upcoming
Northeast GI Oncology Congress 2026
Upcoming
Paris Colon Cancer Congress 2026
